Patents by Inventor Ying Yu Jin

Ying Yu Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic peptide from sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
    Patent number: 9090667
    Abstract: The present invention relates to novel anti-TB cyclic peptides from Nonomuraea sp. MJM5123, a process for the production of the anti-Tuberculosis peptide and a pharmaceutical composition for the prevention and treatment of mycobacterial infection comprising the same. The composition of the present invention is highly active against replicating/non-replicating M. tuberculosis, including MDR and XDR strains, so that it can be effectively used as a therapeutic agent for tuberculosis.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: July 28, 2015
    Assignees: Myongji University Industry and Academia Cooperation Foundation, The Board of Trustees of the University of Illinois
    Inventors: Jong Woo Kim, Sang Wook Lee, Sang Jin Park, Joo Won Suh, In Ae Lee, Tae Mi Yoon, Jong Keun Choi, Ji Ean Lee, Jin Yong Kim, Ying Yu Jin, Scott Franzblau, Sanghyun Cho, Wei Gao, Guido Pauli, James McAlpine, Jose Napolitano, Birgit Jaki, Brent Friesen, Maria Florencia Rodriguez Brasco, David Lankin
  • CYCLIC PEPTIDE FROM NONOMURAEA SP., PROCESS FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MYCOBACTERIA RELATED DISEASE COMPRISING THE SAME
    Publication number: 20140142031
    Abstract: The present invention relates to novel anti-TB cyclic peptides from Nonomuraea sp. MJM5123, a process for the production of the anti-Tuberculosis peptide and a pharmaceutical composition for the prevention and treatment of mycobacterial infection comprising the same. The composition of the present invention is highly active against replicating/non-replicating M. tuberculosis, including MDR and XDR strains, so that it can be effectively used as a therapeutic agent for tuberculosis.
    Type: Application
    Filed: April 18, 2012
    Publication date: May 22, 2014
    Inventors: Jong Woo Kim, Sang Wook Lee, Sang jin Park, Joo Won Suh, In Ae Lee, Tae Mi Yoon, Jong Keun Choi, Ji Ean Lee, Jin Yong Kim, Ying Yu Jin, Scott Franzblau, Sanghyum Cho, Wei Gao, Guido Pauli, James McAlpine, Jose Napolitano, Birgit Jaki, Brent Friesen, Maria Florencia Rodriguez Brasco, David Lankin